LOS ANGELES--(BUSINESS WIRE)--Response Genetics, Inc. (Nasdaq:RGDX) will announce the results of studies in pancreatic cancer, colon cancer and gastric cancer that identify novel biomarkers and genetic profile patterns that are predictive of therapeutic response. Results of these studies will be presented during the 2008 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, which will be held May 30 to June 3.
